Structure

Physi-Chem Properties

Molecular Weight:  486.33
Volume:  538.455
LogP:  5.945
LogD:  4.413
LogS:  -3.818
# Rotatable Bonds:  14
TPSA:  90.15
# H-Bond Aceptor:  5
# H-Bond Donor:  4
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.244
Synthetic Accessibility Score:  3.591
Fsp3:  0.6
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.641
MDCK Permeability:  1.749328112055082e-05
Pgp-inhibitor:  0.803
Pgp-substrate:  0.006
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.604
30% Bioavailability (F30%):  0.476

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.412
Plasma Protein Binding (PPB):  96.96666717529297%
Volume Distribution (VD):  3.54
Pgp-substrate:  3.722943067550659%

ADMET: Metabolism

CYP1A2-inhibitor:  0.162
CYP1A2-substrate:  0.212
CYP2C19-inhibitor:  0.625
CYP2C19-substrate:  0.868
CYP2C9-inhibitor:  0.458
CYP2C9-substrate:  0.864
CYP2D6-inhibitor:  0.871
CYP2D6-substrate:  0.073
CYP3A4-inhibitor:  0.906
CYP3A4-substrate:  0.868

ADMET: Excretion

Clearance (CL):  11.679
Half-life (T1/2):  0.139

ADMET: Toxicity

hERG Blockers:  0.272
Human Hepatotoxicity (H-HT):  0.072
Drug-inuced Liver Injury (DILI):  0.024
AMES Toxicity:  0.022
Rat Oral Acute Toxicity:  0.058
Maximum Recommended Daily Dose:  0.136
Skin Sensitization:  0.177
Carcinogencity:  0.033
Eye Corrosion:  0.003
Eye Irritation:  0.02
Respiratory Toxicity:  0.009

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC261992

Natural Product ID:  NPC261992
Common Name*:   Disydonol A
IUPAC Name:   2-[(2S)-2-hydroxy-6-methylheptan-2-yl]-5-[[5-(hydroxymethyl)-2-[(2S)-2-hydroxy-6-methylheptan-2-yl]phenoxy]methyl]phenol
Synonyms:   Disydonol A
Standard InCHIKey:  UNABCQHOHCCBEK-KYJUHHDHSA-N
Standard InCHI:  InChI=1S/C30H46O5/c1-21(2)9-7-15-29(5,33)25-13-12-24(17-27(25)32)20-35-28-18-23(19-31)11-14-26(28)30(6,34)16-8-10-22(3)4/h11-14,17-18,21-22,31-34H,7-10,15-16,19-20H2,1-6H3/t29-,30-/m0/s1
SMILES:  OCc1ccc(c(c1)OCc1ccc(c(c1)O)[C@](CCCC(C)C)(O)C)[C@](CCCC(C)C)(O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1946640
PubChem CID:   57334110
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota rhizosphere Sonoran desert n.a. PMID[15620238]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17542490]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17564467]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[19053517]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21366228]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21718031]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21854017]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota healthy leaf of Ginkgo biloba campus of Nanjing University, Nanjing, China 2008-OCT PMID[22196792]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota isolated from the sponge Xestospongia testudinaria n.a. n.a. PMID[22225637]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota Isolated from a sandy-loam soil sample 50 m inland from Waikiki Beach, Honolulu, Hawaii 2010-JUL PMID[22400916]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[22703109]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[23527875]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[24050204]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[25001296]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[25581396]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26273902]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[31012585]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[33305943]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens IC50 = 9.31 ug.mL-1 PMID[529683]
NPT2306 Cell Line Ca-Ski Homo sapiens IC50 = 12.4 ug.mL-1 PMID[529683]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC261992 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9914 High Similarity NPC188997
0.92 High Similarity NPC472590
0.8966 High Similarity NPC228452
0.8934 High Similarity NPC77789
0.8934 High Similarity NPC18128
0.8898 High Similarity NPC301321
0.8889 High Similarity NPC472797
0.8871 High Similarity NPC131397
0.8871 High Similarity NPC476254
0.8843 High Similarity NPC474131
0.8833 High Similarity NPC283616
0.881 High Similarity NPC38604
0.881 High Similarity NPC211179
0.876 High Similarity NPC471449
0.876 High Similarity NPC469610
0.876 High Similarity NPC51341
0.876 High Similarity NPC32152
0.874 High Similarity NPC472795
0.874 High Similarity NPC472796
0.8702 High Similarity NPC472800
0.8699 High Similarity NPC48623
0.8699 High Similarity NPC168707
0.8699 High Similarity NPC212965
0.8689 High Similarity NPC232295
0.8682 High Similarity NPC469611
0.8678 High Similarity NPC190514
0.8651 High Similarity NPC283049
0.8651 High Similarity NPC230479
0.8651 High Similarity NPC26879
0.8651 High Similarity NPC50315
0.864 High Similarity NPC61685
0.8629 High Similarity NPC204535
0.8629 High Similarity NPC120638
0.8629 High Similarity NPC46586
0.8618 High Similarity NPC218753
0.8618 High Similarity NPC96423
0.8618 High Similarity NPC45663
0.8615 High Similarity NPC211352
0.8607 High Similarity NPC184302
0.8607 High Similarity NPC151197
0.8605 High Similarity NPC153019
0.8605 High Similarity NPC8899
0.8595 High Similarity NPC187993
0.8595 High Similarity NPC238176
0.8594 High Similarity NPC93962
0.8594 High Similarity NPC96719
0.8594 High Similarity NPC222108
0.8583 High Similarity NPC473221
0.8583 High Similarity NPC46978
0.8583 High Similarity NPC232165
0.8571 High Similarity NPC81641
0.8561 High Similarity NPC327735
0.8561 High Similarity NPC126101
0.856 High Similarity NPC474130
0.856 High Similarity NPC96940
0.8538 High Similarity NPC472798
0.8534 High Similarity NPC66834
0.8525 High Similarity NPC63010
0.8516 High Similarity NPC38664
0.8516 High Similarity NPC53986
0.8512 High Similarity NPC69539
0.8504 High Similarity NPC82299
0.85 High Similarity NPC470837
0.8492 Intermediate Similarity NPC248557
0.8492 Intermediate Similarity NPC270030
0.8487 Intermediate Similarity NPC474920
0.8468 Intermediate Similarity NPC100108
0.8468 Intermediate Similarity NPC129176
0.8468 Intermediate Similarity NPC277798
0.8462 Intermediate Similarity NPC211413
0.8462 Intermediate Similarity NPC68205
0.8462 Intermediate Similarity NPC244888
0.8462 Intermediate Similarity NPC164804
0.8462 Intermediate Similarity NPC293203
0.8462 Intermediate Similarity NPC118683
0.8455 Intermediate Similarity NPC121866
0.8455 Intermediate Similarity NPC137294
0.8455 Intermediate Similarity NPC85895
0.845 Intermediate Similarity NPC16577
0.8443 Intermediate Similarity NPC470759
0.8443 Intermediate Similarity NPC15860
0.8443 Intermediate Similarity NPC219070
0.8443 Intermediate Similarity NPC69261
0.8443 Intermediate Similarity NPC33270
0.8443 Intermediate Similarity NPC127894
0.8438 Intermediate Similarity NPC66331
0.8433 Intermediate Similarity NPC183781
0.843 Intermediate Similarity NPC808
0.843 Intermediate Similarity NPC473718
0.8425 Intermediate Similarity NPC4286
0.8425 Intermediate Similarity NPC76119
0.8421 Intermediate Similarity NPC141717
0.8421 Intermediate Similarity NPC476698
0.8413 Intermediate Similarity NPC474160
0.8413 Intermediate Similarity NPC280704
0.8409 Intermediate Similarity NPC478085
0.8397 Intermediate Similarity NPC27578
0.8397 Intermediate Similarity NPC13005
0.8397 Intermediate Similarity NPC289624
0.8387 Intermediate Similarity NPC328485
0.8385 Intermediate Similarity NPC475880
0.8374 Intermediate Similarity NPC139047
0.8374 Intermediate Similarity NPC9592
0.8374 Intermediate Similarity NPC48781
0.8372 Intermediate Similarity NPC39064
0.8372 Intermediate Similarity NPC274717
0.8372 Intermediate Similarity NPC47288
0.8372 Intermediate Similarity NPC47283
0.8361 Intermediate Similarity NPC290470
0.8361 Intermediate Similarity NPC154256
0.8361 Intermediate Similarity NPC150624
0.8361 Intermediate Similarity NPC114064
0.8358 Intermediate Similarity NPC134260
0.8333 Intermediate Similarity NPC269528
0.8333 Intermediate Similarity NPC150026
0.8333 Intermediate Similarity NPC26394
0.8333 Intermediate Similarity NPC77196
0.8333 Intermediate Similarity NPC85488
0.8333 Intermediate Similarity NPC302211
0.8321 Intermediate Similarity NPC160623
0.8321 Intermediate Similarity NPC280653
0.8321 Intermediate Similarity NPC477616
0.8321 Intermediate Similarity NPC164574
0.8321 Intermediate Similarity NPC118114
0.8321 Intermediate Similarity NPC228369
0.8321 Intermediate Similarity NPC300875
0.8321 Intermediate Similarity NPC196765
0.8321 Intermediate Similarity NPC129784
0.8321 Intermediate Similarity NPC271945
0.8321 Intermediate Similarity NPC476166
0.8321 Intermediate Similarity NPC471517
0.8321 Intermediate Similarity NPC17343
0.8321 Intermediate Similarity NPC181497
0.8321 Intermediate Similarity NPC206224
0.8321 Intermediate Similarity NPC207892
0.8321 Intermediate Similarity NPC284232
0.8321 Intermediate Similarity NPC162801
0.8321 Intermediate Similarity NPC150011
0.8321 Intermediate Similarity NPC12875
0.8321 Intermediate Similarity NPC236014
0.8321 Intermediate Similarity NPC268917
0.8321 Intermediate Similarity NPC129106
0.832 Intermediate Similarity NPC212559
0.832 Intermediate Similarity NPC473875
0.8308 Intermediate Similarity NPC134360
0.8305 Intermediate Similarity NPC75440
0.8305 Intermediate Similarity NPC201959
0.8305 Intermediate Similarity NPC169450
0.8305 Intermediate Similarity NPC241549
0.8296 Intermediate Similarity NPC471388
0.8295 Intermediate Similarity NPC5428
0.8295 Intermediate Similarity NPC469386
0.8295 Intermediate Similarity NPC257947
0.8293 Intermediate Similarity NPC50521
0.8293 Intermediate Similarity NPC244816
0.8293 Intermediate Similarity NPC221549
0.8286 Intermediate Similarity NPC212142
0.8284 Intermediate Similarity NPC477939
0.8284 Intermediate Similarity NPC54743
0.8284 Intermediate Similarity NPC173660
0.8284 Intermediate Similarity NPC156502
0.8284 Intermediate Similarity NPC265433
0.8284 Intermediate Similarity NPC162659
0.8284 Intermediate Similarity NPC29799
0.8284 Intermediate Similarity NPC209985
0.8284 Intermediate Similarity NPC263367
0.8284 Intermediate Similarity NPC10737
0.8284 Intermediate Similarity NPC270456
0.8284 Intermediate Similarity NPC248727
0.8284 Intermediate Similarity NPC177160
0.8281 Intermediate Similarity NPC105031
0.8281 Intermediate Similarity NPC170749
0.8279 Intermediate Similarity NPC53906
0.8276 Intermediate Similarity NPC323810
0.8276 Intermediate Similarity NPC475225
0.8271 Intermediate Similarity NPC115335
0.8271 Intermediate Similarity NPC225696
0.8271 Intermediate Similarity NPC198154
0.8271 Intermediate Similarity NPC296915
0.8271 Intermediate Similarity NPC473107
0.8271 Intermediate Similarity NPC223008
0.8271 Intermediate Similarity NPC97834
0.8268 Intermediate Similarity NPC38761
0.8268 Intermediate Similarity NPC76465
0.8264 Intermediate Similarity NPC35344
0.8264 Intermediate Similarity NPC141003
0.8264 Intermediate Similarity NPC261343
0.8258 Intermediate Similarity NPC230219
0.8254 Intermediate Similarity NPC476633
0.8254 Intermediate Similarity NPC475839
0.8254 Intermediate Similarity NPC54972
0.8254 Intermediate Similarity NPC193364
0.825 Intermediate Similarity NPC275627
0.8244 Intermediate Similarity NPC470727
0.8244 Intermediate Similarity NPC27187
0.8244 Intermediate Similarity NPC470225
0.8244 Intermediate Similarity NPC196193
0.8235 Intermediate Similarity NPC474272
0.8235 Intermediate Similarity NPC472794
0.8235 Intermediate Similarity NPC473049

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC261992 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8739 High Similarity NPD6671 Approved
0.8672 High Similarity NPD6410 Clinical (unspecified phase)
0.856 High Similarity NPD4749 Approved
0.845 Intermediate Similarity NPD4625 Phase 3
0.8372 Intermediate Similarity NPD4908 Phase 1
0.8295 Intermediate Similarity NPD2861 Phase 2
0.8254 Intermediate Similarity NPD1610 Phase 2
0.8244 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.8211 Intermediate Similarity NPD7340 Approved
0.8136 Intermediate Similarity NPD968 Approved
0.8125 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.812 Intermediate Similarity NPD4060 Phase 1
0.8062 Intermediate Similarity NPD6696 Suspended
0.7985 Intermediate Similarity NPD1613 Approved
0.7985 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7984 Intermediate Similarity NPD7157 Approved
0.7967 Intermediate Similarity NPD1398 Phase 1
0.7956 Intermediate Similarity NPD6099 Approved
0.7956 Intermediate Similarity NPD6100 Approved
0.7937 Intermediate Similarity NPD1548 Phase 1
0.7917 Intermediate Similarity NPD290 Approved
0.7914 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD2232 Approved
0.7907 Intermediate Similarity NPD2231 Phase 2
0.7907 Intermediate Similarity NPD2230 Approved
0.7907 Intermediate Similarity NPD2235 Phase 2
0.7907 Intermediate Similarity NPD2233 Approved
0.7895 Intermediate Similarity NPD3027 Phase 3
0.7891 Intermediate Similarity NPD3496 Discontinued
0.7886 Intermediate Similarity NPD7843 Approved
0.7886 Intermediate Similarity NPD7635 Approved
0.7863 Intermediate Similarity NPD2797 Approved
0.7851 Intermediate Similarity NPD2684 Approved
0.7829 Intermediate Similarity NPD1611 Approved
0.7823 Intermediate Similarity NPD5283 Phase 1
0.782 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD6584 Phase 3
0.7787 Intermediate Similarity NPD4750 Phase 3
0.777 Intermediate Similarity NPD5763 Approved
0.777 Intermediate Similarity NPD5762 Approved
0.7762 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD288 Approved
0.7744 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7734 Intermediate Similarity NPD5585 Approved
0.773 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7721 Intermediate Similarity NPD2238 Phase 2
0.771 Intermediate Similarity NPD5327 Phase 3
0.7708 Intermediate Similarity NPD6090 Discontinued
0.7704 Intermediate Similarity NPD3268 Approved
0.7692 Intermediate Similarity NPD1091 Approved
0.7674 Intermediate Similarity NPD4626 Approved
0.7674 Intermediate Similarity NPD1778 Approved
0.7672 Intermediate Similarity NPD844 Approved
0.7664 Intermediate Similarity NPD6355 Discontinued
0.7664 Intermediate Similarity NPD5735 Approved
0.763 Intermediate Similarity NPD7095 Approved
0.7627 Intermediate Similarity NPD3020 Approved
0.7609 Intermediate Similarity NPD4097 Suspended
0.7609 Intermediate Similarity NPD6653 Approved
0.7609 Intermediate Similarity NPD6353 Approved
0.7606 Intermediate Similarity NPD3892 Phase 2
0.7597 Intermediate Similarity NPD3444 Approved
0.7597 Intermediate Similarity NPD5691 Approved
0.7597 Intermediate Similarity NPD3443 Approved
0.7597 Intermediate Similarity NPD3445 Approved
0.7591 Intermediate Similarity NPD4140 Approved
0.7576 Intermediate Similarity NPD6582 Phase 2
0.7576 Intermediate Similarity NPD6583 Phase 3
0.7574 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7559 Intermediate Similarity NPD2557 Approved
0.7551 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7535 Intermediate Similarity NPD6674 Discontinued
0.7519 Intermediate Similarity NPD8651 Approved
0.75 Intermediate Similarity NPD4308 Phase 3
0.75 Intermediate Similarity NPD3021 Approved
0.75 Intermediate Similarity NPD3022 Approved
0.75 Intermediate Similarity NPD7033 Discontinued
0.75 Intermediate Similarity NPD1608 Approved
0.7481 Intermediate Similarity NPD2237 Approved
0.7481 Intermediate Similarity NPD1712 Approved
0.746 Intermediate Similarity NPD5535 Approved
0.7448 Intermediate Similarity NPD6087 Phase 1
0.7447 Intermediate Similarity NPD6032 Approved
0.7447 Intermediate Similarity NPD2935 Discontinued
0.7445 Intermediate Similarity NPD7985 Registered
0.7444 Intermediate Similarity NPD4359 Approved
0.7442 Intermediate Similarity NPD7644 Approved
0.7422 Intermediate Similarity NPD709 Approved
0.7422 Intermediate Similarity NPD6387 Discontinued
0.7417 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD5177 Phase 3
0.7407 Intermediate Similarity NPD4624 Approved
0.7407 Intermediate Similarity NPD3690 Phase 2
0.7407 Intermediate Similarity NPD3691 Phase 2
0.7405 Intermediate Similarity NPD2667 Approved
0.7405 Intermediate Similarity NPD5846 Approved
0.7405 Intermediate Similarity NPD2668 Approved
0.7405 Intermediate Similarity NPD6516 Phase 2
0.7391 Intermediate Similarity NPD7265 Discontinued
0.7391 Intermediate Similarity NPD7477 Discontinued
0.7388 Intermediate Similarity NPD1283 Approved
0.7381 Intermediate Similarity NPD228 Approved
0.7373 Intermediate Similarity NPD2859 Approved
0.7373 Intermediate Similarity NPD2860 Approved
0.7351 Intermediate Similarity NPD5929 Approved
0.7343 Intermediate Similarity NPD2424 Discontinued
0.7343 Intermediate Similarity NPD7037 Approved
0.7339 Intermediate Similarity NPD2342 Discontinued
0.7338 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD3620 Phase 2
0.7338 Intermediate Similarity NPD2979 Phase 3
0.7333 Intermediate Similarity NPD3266 Approved
0.7333 Intermediate Similarity NPD6362 Approved
0.7333 Intermediate Similarity NPD3267 Approved
0.7329 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD7041 Phase 2
0.7328 Intermediate Similarity NPD3049 Approved
0.7328 Intermediate Similarity NPD1651 Approved
0.7323 Intermediate Similarity NPD821 Approved
0.7319 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7319 Intermediate Similarity NPD6798 Discontinued
0.7313 Intermediate Similarity NPD3685 Discontinued
0.7305 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD4538 Approved
0.7305 Intermediate Similarity NPD4536 Approved
0.7305 Intermediate Similarity NPD7097 Phase 1
0.7299 Intermediate Similarity NPD596 Approved
0.7299 Intermediate Similarity NPD6832 Phase 2
0.7299 Intermediate Similarity NPD600 Approved
0.7293 Intermediate Similarity NPD422 Phase 1
0.7288 Intermediate Similarity NPD2934 Approved
0.7288 Intermediate Similarity NPD2933 Approved
0.7286 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7286 Intermediate Similarity NPD5124 Phase 1
0.7279 Intermediate Similarity NPD558 Phase 2
0.7279 Intermediate Similarity NPD7447 Phase 1
0.7279 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6002 Phase 3
0.7273 Intermediate Similarity NPD17 Approved
0.7273 Intermediate Similarity NPD6005 Phase 3
0.7273 Intermediate Similarity NPD6004 Phase 3
0.7273 Intermediate Similarity NPD2346 Discontinued
0.7273 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7266 Intermediate Similarity NPD840 Approved
0.7266 Intermediate Similarity NPD839 Approved
0.726 Intermediate Similarity NPD6666 Approved
0.726 Intermediate Similarity NPD6667 Approved
0.7259 Intermediate Similarity NPD3225 Approved
0.7254 Intermediate Similarity NPD2156 Approved
0.7254 Intermediate Similarity NPD2154 Approved
0.7254 Intermediate Similarity NPD2155 Approved
0.7252 Intermediate Similarity NPD1182 Approved
0.7252 Intermediate Similarity NPD3091 Approved
0.7241 Intermediate Similarity NPD4628 Phase 3
0.7239 Intermediate Similarity NPD1840 Phase 2
0.7234 Intermediate Similarity NPD2157 Approved
0.7231 Intermediate Similarity NPD3596 Phase 2
0.7222 Intermediate Similarity NPD5451 Approved
0.7214 Intermediate Similarity NPD4307 Phase 2
0.7214 Intermediate Similarity NPD3597 Clinical (unspecified phase)
0.7206 Intermediate Similarity NPD1203 Approved
0.7206 Intermediate Similarity NPD4098 Discontinued
0.7206 Intermediate Similarity NPD3094 Phase 2
0.7203 Intermediate Similarity NPD845 Approved
0.7203 Intermediate Similarity NPD1551 Phase 2
0.7197 Intermediate Similarity NPD6830 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD3056 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD2677 Approved
0.7188 Intermediate Similarity NPD1138 Approved
0.7185 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7164 Intermediate Similarity NPD1535 Discovery
0.7164 Intermediate Similarity NPD1281 Approved
0.7163 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD7030 Discontinued
0.7143 Intermediate Similarity NPD6233 Phase 2
0.7143 Intermediate Similarity NPD2554 Approved
0.7143 Intermediate Similarity NPD4870 Approved
0.7143 Intermediate Similarity NPD2556 Approved
0.7143 Intermediate Similarity NPD2107 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6815 Approved
0.7133 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD5960 Phase 3
0.7133 Intermediate Similarity NPD4108 Discontinued
0.7133 Intermediate Similarity NPD5588 Approved
0.7133 Intermediate Similarity NPD2370 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD2799 Discontinued
0.7124 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD7466 Approved
0.7123 Intermediate Similarity NPD4110 Phase 3
0.7123 Intermediate Similarity NPD7976 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7121 Intermediate Similarity NPD6580 Approved
0.7121 Intermediate Similarity NPD1894 Discontinued
0.7121 Intermediate Similarity NPD6581 Approved
0.7111 Intermediate Similarity NPD1481 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data